Dr. Reddy’s announced the re-launch of Zenatane (isotretinoin capsules) for the treatment of severe recalcitrant lumpy acne unresponsive to conventional treatment (eg, systemic antibiotics).

Zenatane, a therapeutic equivalent of Accutane, is only approved for sale under a Special Restricted Distribution Program (iPLEDGE) approved by the Food and Drug Administration (FDA) because it can cause serious malformations. congenital. To prescribe and dispense Zenatane, prescribers and pharmacies must be enrolled in the iPLEDGE program; Zenatane can only be dispensed to patients who are also registered and meet all iPLEDGE requirements.

The product is available in capsules of 10 mg, 20 mg, 30 mg and 40 mg and is supplied in blister packs of 3 × 10 (30 units). “We are delighted to bring this important product back to market for customers and patients who will benefit from access to this drug and who have witnessed limited supply and options in the market,” said Marc Kikuchi , Managing Director, North America. Generics.

For more information, visit drreddys.com.

Continue reading